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Abstract 
Background and aim Scientific literature offers few measurements of the 
quantities consumed by individual drug users. Such measurements are used for 
calculating the total drug consumption by the quantity-–frequency method, and are 
extremely important for the comparison with waste water derived consumption 
estimates. The aim of this study was to measure quantities of amphetamines, cocaine 
and heroin consumed by marginalized drug users, using a multi-city questionnaire 
survey design. Variation by gender, age, frequency of use, main drug used and city 
was explored. 
Results The self-reported quantity used on the last day of use was for amphetamines 
on average 800 mg, for cocaine 1014 mg and for heroin 682 mg. The self-reported 
usual dose was on average 297 mg, 487 mg and 297 mg respectively, while the 
median value was 250 mg for all three drugs. Overall, gender and age group were less 
important than frequency of use and the main drug used for establishing differences 
regarding the outcome variables. There were some differences regarding cities. No 
measure of purity was carried out at the interview sites, so the calculation of pure 
quantities was based on aggregate results from analyses of seizures by police and 
customs. 
Conclusions The self-reported quantities of drugs consumed in three cities in 
Norway was equal to or somewhat higher among marginalized users than earlier 
assumed, where assumptions were based on limited literature and anecdotal 
information. 
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1 Introduction 
The methods for monitoring drug use and estimating the quantities of drugs 
consumed and market sizes have been supplemented with the new method of 
measuring illegal drugs in waste water (Frost and Griffiths, 2008; Reid et al., 2011). 
Estimation of the size of drug markets has so far been carried out either using 
information from the production side or from the demand side (Bramley-Harker, 
2001). The demand side approach employs data on the number of users, their 
frequency of use, and the quantities consumed, often called the quantity/frequency 
(QF) method. In a study by Reid et al. (2012) the waste water and QF method for 
estimating cocaine consumption were compared for the city of Oslo, Norway. No 
significant differences were found regarding results from the QF approach and the 
waste water approach. It was surprising, however, that the figure from the QF 
approach was the highest. The QF approach tends to underestimate alcohol 
consumption for a country, as compared to sales and production data. 
Underestimation may vary from 30% to 70% (Babor et al., 2010). At the moment, a 
major weakness in using the QF method to estimate the consumption of illegal drugs 
is the scarcity of information about quantities consumed (Reid et al., 2012; 
Mckeganey et al., 2009). To be able to improve the comparisons of methods for 
consumption estimation, more studies measuring quantities of use for different user 
populations should be carried out. 
Comparisons of methods estimating consumption will also depend on the 
purity of the drug. This is very seldom controlled at the street level in surveys (Evrard 
et al., 2010). Figures on purity may vary over time, place and with the level in the 
sales system. Cutting the drug, i.e. mixing it with another matter to obtain a larger 
profit, may vary by drug dealer organization or route of transport. Cutting also 
happens at the last sale or user level to get an enhanced effect. Figures regarding drug 
purity are usually derived from seizures by the police or customs. 
The aim of this study was to measure the quantities of amphetamines, cocaine 
and heroin consumed among marginalized drug users, using a multi-city 
questionnaire survey design. Variation by gender, age, frequency of use, main drug 
use and city was explored. Illustrations of the quantity of pure drugs consumed are 
also given. 
2 Material and methods 
For this study, eligible persons were those 18 years and over who had used 
amphetamines, cocaine, heroin, or other opioids during the last 12 months in three 
cities: Arendal, with 42,000 inhabitants (interviews conducted in 2010); Tromsø, 
with 71,000 inhabitants (interviews conducted in 2011–2012); and Oslo, with 625 
,000 inhabitants (interviews conducted in 2012). “Amphetamines” were specified in 
the questionnaire to include amphetamine and methamphetamine, while “cocaine” 
also included crack. “Heroin” included the specific substance only, while “other 
opioids” included all other natural, semi-synthetic and synthetic types of opiates and 
opioids, both prescribed and not prescribed. The questionnaire included a long list of 
substances and corresponding brand names for clarification. Respondents were 
recruited by contact established via local social workers and administrative staff 
working in services for marginalized drug users¸ both non-governmental and public. 
Posters announced the aim of the survey and periods of interviewing at the different 
services. Most interviews were conducted in calm areas or separate café rooms, low 
threshold services or hostels/shelters, while some were conducted in the streets just 
outside such premises. No random mechanism for choosing cites to interview was 
employed, but in each city, researchers visited several sites aimed at marginalized 
users in different situations. Interviews were conducted by the project leader and 
social science or social work students who received 5 h of training. The interviews 
lasted from 20 to 30 min, and compensation of NOK 200 ($35) was given after the 
interview. 
The questionnaire included questions mainly about the types of drugs used 
and their frequency of use and quantity. In addition, some demographic and 
background information was requested, such as gender, age group, continent of birth, 
education level and type of dwelling. In Arendal and Tromsø an additional question 
regarding “mainly weekend use” vs. “use any other day of the week” was included. 
An anonymous dataset was preferred and this was developed in collaboration 
with the Norwegian Social Science Data Services (NSD), which is the partner of the 
Norwegian Data Inspectorate for implementation of the statutory data privacy 
requirements in the research community. The project was approved by The National 
Committee for Research Ethics in the Social Sciences and the Humanities. 
The inclusion criterion for the study was use of amphetamines, cocaine/crack, 
heroin or opioids in the last 12 months. In this analysis, only those who had taken 
such drugs during the last 30 days were included. This was done to reduce the recall 
bias regarding quantities consumed. 
Injecting drugs, as opposed to other methods of administration, is very 
common among marginalized drug users in Norway. Both amphetamine and 
methamphetamine are sold as powders on the black market and are often injected. 
The opioids include a wide range of substances: opium, heroin (the brown type is 
dominating), methadone (mainly as a fluid), Subutex and a long range of drugs such 
as Dolcontin, OxyContin and Temgesic (tablets). Heroin is mainly injected and 
tablets are also often crushed and injected. Information on quantities of opioids other 
than heroin was not complete due to the wide range of such drugs. Results are 
therefore only shown for amphetamines, cocaine and heroin. 
The significance of the differences in the outcome variables by gender, age, the 
drug most frequently used, the frequency of the actual drug use over the last 30 days, 
and city was tested using a linear regression, both unadjusted (simple) and adjusted 
(multiple). A five per cent level was used for all significant tests. The usual formula 
for confidence intervals of normally distributed variables was applied with 95% levels 
(mean ± 1.96 ∗ standard error of mean). 
A few reported very high quantities and doses. It was not possible to 
distinguish between true and biased values or errors. To avoid high values that might 
make averages artificially high, these values were reduced to a maximum 3000 mg 
for a day's use (24 h) and maximum 1000 mg for a dose. Five values were reduced for 
amphetamines, 13 for cocaine and four for heroin. 
3 Theory/calculation 
Drug consumption and drug use patterns can a priori vary between cities and 
geographical areas. Therefore three cities of varying size, geographically spread in 
Norway, were chosen. The low number of cities implies, together with the lack of a 
random selection mechanism, that the results cannot be generalized to the national 
level. 
Marginalized drug users taking amphetamines, cocaine/crack or heroin are 
seldom dedicated users of only one of these substances. Poly drug use is common, 
including also other substances like cannabis, opioids, alcohol, ecstasy etc. Many 
prefer a specific substance, however, and then develop a tolerance for or gain habits 
of a high level of use of that substance. Therefore the variables “main substance used” 
and “frequency of use” were a priori important for the quantity consumed. Gender 
and age may also be associated with quantities used. 
The intake of amphetamines, cocaine and heroin will vary over the week, 
month and year. For marginalized users, periods of abstinence will occur, either due 
to periods in prison or in treatment or as a personal choice. It is therefore not a 
simple task to create a set of questions which produce unbiased estimates of 
quantities consumed per day, per week, per month or per year. This study first asked 
about lifetime consumption for each of the main substances, then about how many of 
the last 12 months the respondents took them, then how often each substance was 
taken during the months of consumption (once a month; monthly, but not more than 
2–3 times per month; 1–3 times per week; daily or almost daily (4–7 times per week)). 
The study then asked whether the substance was taken during the last 30 days, and 
finally, over how many days it was taken during the last 30 days. 
The quantity outcome questions for amphetamines were: 
1. 
The last time (24 h) you took amphetamines, how much did you take 
altogether? 
2. 
Usually, how big is your single dose of amphetamines? 
Both answers were reported in grams. The questions were similar for cocaine 
(including crack) and heroin. 
Aggregate information published by the central police laboratories regarding 
the purity of seized substances in 2011, both from customs and police, has been 
employed to estimate the purity of the drug consumed (Kripos, 2011). Table 1 shows 
the variation in purity in seizures by police and customs as well as the average purity. 
The variation in purity is substantial, regardless of whether the seizure was of street 
doses or larger border crossing quantities. This finding matches the general 
perception of law enforcement agencies in Norway that suggests that most of the 
cutting is carried out outside Norwegian borders. Since the variations in large and 
small quantities are similar, the total mean of purity may thus well be close to the 
true value for small quantities sold. Purity at the consumption level (small doses) has 
to be the preferred information, however not available. 
Table 1 Purity in seizures of drugs. 2011. Per cent. 
Type of drug Variation in all seizures Variation in 7–8 largest seizures Average 
Amphetamines 1 - –90 8 - –65 44 
Cocaine .. 20 - –75 33 
Heroin < 1 - –70 < 1 - –6 15 
4 Results 
The total number of respondents was 413, of which 339 (82 %) had used 
amphetamines, cocaine/crack or heroin the last 30 days and were thus included in 
the subsample studied here. Of the 339 respondents, 23% were women, 24 % were 
less than 34 years of age and 44% were older than 45 years of age. Amphetamines 
were the drugs most commonly used over the last 30 days (83 %) while 71% had used 
heroin and 17% cocaine. Forty percent reported that heroin was the drug most 
frequently used over the last 12 months, followed by 31% reporting amphetamines 
and 1% reporting cocaine. Others reported other opioids as their most commonly 
used drug the last 12 months. Among users of amphetamines, 38% reported more 
than 20 days of use over the last 30 days. Comparable figures for cocaine were 2% 
and 43% for heroin. In the two smaller cities 12% (n = 68) of the amphetamines users 
consumed it mainly at week-ends. Comparable figures were 0% (n = 7) for cocaine 
users and 6% (n = 34) for heroin users. Finally, 33 respondents (10 %) were from 
Arendal, 53 (16 %) from Tromsø and 253 (75 %) from Oslo. 
The average self-reported quantities used during the last day of use and the 
usual dose of amphetamines, cocaine and heroin are shown in Table 2 for those who 
had used the drug in the last 30 days. Results are also shown for gender, age group, 
the actual drug most frequently used last year, frequency of use of the actual drug 
during the last 30 days, and city. The usual doses were higher than the commonly 
mentioned 200 or 250 mg, especially for cocaine. The median dose was 250 mg for all 
three substances, however. On average, the quantities consumed on the last day of 
use were 2.7 usual doses of amphetamines, 2.1 usual doses of cocaine and 2.3 usual 
doses of heroin. Injecting was the common method of administration for 
amphetamines (86 % among users last 30 days) and heroin (93 % among users last 
30 days). Among cocaine users over the last 30 days, 31% had injected the drug. 
Table 2 Self-reported quantity used last day of use and usual dose among users last 
30 days. Amphetamines, cocaine, heroin. Gender, age, most frequently used drug last 
12 months, frequency of use last 30 days, city. Average with confidence intervals (CI). 
Milligrams. Number of observations (n =). 
 Amphetamines Cocaine Heroin 
Quantity last 
day of use (CI) 
Usual 
dose (CI) 
Quantity last 
day of use (CI) 
Usual 
dose (CI) 
Quantity last 
day of use (CI) 
Usual 
dose 
(CI) 
All 800 (721–879) 
n = 277 
297 
(280–
315) 
n = 277 
1014 (757–
1291) 
n = 53 
487 
(379–
595) 
n = 45 
682 (605–760) 
n = 236 
297 
(278–
317) 
n = 239 
Gender       
Males 812 (720–903) 
n = 213 
311 
(290–
333) 
n = 211 
1015 (722–
1309) 
n = 43 
476 
(354–
599) 
n = 36 
674 (588–760) 
n = 177 
306 
(283–
329) 
n = 179 
Females 760 (602–919) 253 
(230–
1010 (233–
1787) 
528 
(245–
708 (533–883) 271 
(236–
 Amphetamines Cocaine Heroin 
Quantity last 
day of use (CI) 
Usual 
dose (CI) 
Quantity last 
day of use (CI) 
Usual 
dose (CI) 
Quantity last 
day of use (CI) 
Usual 
dose 
(CI) 
n = 64 276) 
n = 66 
n = 10 811) 
n = 9 
n = 59 307) 
n = 60 
Age       
18-–34 years 800 (655–945) 
n = 79 
297 
(260–
333) 
n = 78 
1305 (716–
1892) 
n = 14 
490 
(220–
760) 
n = 10 
778 (611–946) 
n = 59 
291 
(254–
328) 
n = 59 
35-–44 years 867 (721–
1013) 
n = 100 
311 
(281–
342) 
n = 101 
880 (450–
1310) 
n = 25 
457 
(310–
603) 
n = 23 
604 (486–723) 
n = 84 
280 
(249–
312) 
n = 86 
45 years and 
over 
731 (609–853) 
n = 98 
282 
(258–
308) 
n = 98 
964 (521–
1407) 
n = 14 
542 
(283–
801) 
n = 12 
692 (563–821) 
n = 93 
317 
(284–
349) 
n = 94 
Most frequently 
used drug 
      
Yes 1088 (936–
1239) 
n = 105 
353 
(321–
387) 
n = 104 
1700 (485–
2914) 
n = 3 
410 (0–
859) 
n = 2 
882 (756–
1008) 
n = 131 
318 
(293–
344) 
n = 131 
No 583 (518–649) 
n = 172 
256 
(240–
272) 
n = 173 
880 (725–
1034) 
n = 50 
381 
(320–
441) 
n = 43 
508 (437–579) 
n = 105 
268 
(242–
293) 
n = 108 
Frequency of use 
last 30 days 
      
1-–3 days 490 (372–608) 
n = 45 
262 
(219–
305) 
n = 44 
647 (457–837) 
n = 36 
409 
(282–
535) 
n = 29 
480 (348–612) 
n = 49 
299 
(246–
350) 
n = 50 
4-–9 days 604 (451–789) 
n = 42 
242 
(209–
274) 
n = 42 
1500 (0–3242) 
n = 5 
500 (0–
1175) 
n = 4 
146 (297–534) 
n = 25 
228 
(182–
275) 
n = 26 
10-–19 days 684 (543–825) 
n = 61 
282 
(252–
312) 
n = 61 
1290 (0–2750) 
n = 5 
840 
(396–
1284) 
n = 5 
464 (288–639) 
n = 20 
230 
(178–
282) 
n = 20 
20 days or more 1030 (896– 336 
(307–
2357 (1483– 550 
(233–
835 (723–946) 320 
(296–
 Amphetamines Cocaine Heroin 
Quantity last 
day of use (CI) 
Usual 
dose (CI) 
Quantity last 
day of use (CI) 
Usual 
dose (CI) 
Quantity last 
day of use (CI) 
Usual 
dose 
(CI) 
1165) 
n = 128 
365) 
n = 128 
3231) 
n = 7 
867) 
n = 7 
n = 141 343) 
n = 142 
City       
Arendal 1159 (917–
1400) 
n = 30 
350 
(293–
407) 
n = 30 
1213 (498–
1927) 
n = 4 
163 (80–
245) 
n = 4 
596 (329–863) 
n = 13 
203 
(139–
267) 
n = 13 
Tromsø 862 (677–
1047) 
n = 49 
280 
(254–
305) 
n = 49 
1000 (394–
1606) 
n = 3 
225 
(140–
310) 
n = 2 
456 (340–571) 
n = 29 
210 
(167–
252) 
n = 32 
Oslo 669 (590–750) 
n = 198 
283 
(263–
304) 
n = 198 
885 (717–
1053) 
n = 46 
420 
(352–
488) 
n = 39 
743 (655–832) 
n = 197 
319 
(299–
339) 
n = 194 
In Table 3, both unadjusted and adjusted coefficients of the linear regression 
for the quantity consumed on the last day of use are shown, as well as the significance 
of the factors. Overall, gender and age group were less important than frequency of 
use and the main drug used for establishing differences regarding the outcome 
variable. There were some differences regarding cities. Table 4 shows the same 
results for the usual dose. The most frequently used drug and frequency of use were 
significant only for amphetamine use in the adjusted analyses. 
Table 3 Self-reported quantities used last day of use among users last 30 days of 
amphetamines, cocaine and heroin. Regression coefficients on gender, age, the drug 
being the most frequently used last 12 months, frequency of its use last 30 days, city. 
Milligrams. 
 Amphetamines (n = 277) Cocaine (n = 53) Heroin (n = 236) 
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Constant a 450 a 1105 a 576 
Gender       
Females − 51 − 35 − 5 − 141 34 21 
Males b 0 0 0 0 0 0 
Age       
18-–24 years b 0 0 0 0 0 0 
35-–44 years 67 37 − 424 − 400 − 174 − 208⁎ 
45 years and over − 69 − 106 − 339 − 236 − 86 − 71 
 Amphetamines (n = 277) Cocaine (n = 53) Heroin (n = 236) 
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Most frequently used drug       
Yes 503⁎ 375⁎ 1045 661 363⁎ 177 
No b 0 0 0 0 0 0 
Frequency of use       
0-–19 days b 0 0 0 0 0 0 
20 days or more 429⁎ 387⁎ 1547⁎ 1547⁎ 378⁎ 223⁎ 
City       
Arendal 429⁎ 377⁎ 55 − 608 − 297 − 121 
Tromsø 211⁎ 120 − 595 − 364 − 370⁎ − 183 
Oslo b 0 0 0 0 0 0 
aConstant varies by variable. 
bReference category. 
⁎Significant at 0.05 level. 
Table 4 Usual dose among users last 30 days of amphetamines, cocaine and heroin. 
Regression coefficients on gender, age, the drug being the most frequently used last 
12 months, frequency of its use last 30 days, city. Milligrams. 
 Amphetamines (n = 277) Cocaine (n = 53) Heroin (n = 236) 
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Constant a 259 a 544 a 314 
Gender       
Females − 59⁎ − 54⁎ 51 12 − 35 − 30 
Males b 0 0 0 0 0 0 
Age       
18-–24 years b 0 0 0 0 0 0 
35-–44 years 15 5 − 33 − 70 − 10 − 25 
45 years and over − 13 − 33 51 1 26 15 
Most frequently used drug       
Yes 104⁎ 92⁎ 66 197 41⁎ 5 
No b 0 0 0 0 0 0 
Frequency of use       
0-–19 days b 0 0 0 0 0 0 
20 days or more 72⁎ 54⁎ 75 80 55⁎ 17 
City       
Arendal 66⁎ 41 − 378 − 463 − 112⁎ − 104⁎ 
Tromsø 5⁎ − 17 − 353 − 335 − 116⁎ − 104⁎ 
Oslo b 0 0 0 0 0 0 
aConstant varies by variable. 
bReference category. 
⁎Significant at 0.05 level. 
For the estimation of the quantity of the pure drug consumed, the mean purity 
in 2011 (see Table 1) as reported from seizures by police and customs was applied, see 
Table 5. No confidence intervals are shown since they can be calculated from Table 2 
using the given purity. 
Table 5 Estimated pure quantity used last day of use and pure usual dose among 
users last 30 days. Amphetamines (purity 44 %), cocaine (purity 33 %), heroin (15 %). 
Most frequently used drug last 12 months, frequency of use last 30 days, city. 
Average. Milligrams. 
 Amphetamines Cocaine Heroin 
Quantity last 
day of use, 
pure (n = 277) 
Usual 
dose, pure 
(n = 277) 
Quantity last 
day of use, 
pure (n = 53) 
Usual 
dose, 
pure (n = 
45) 
Quantity last 
day of use, 
pure (n = 236) 
Usual 
dose, pure 
(n = 239) 
All 352 131 335 161 102 45 
Gender       
Males 357 137 335 157 101 46 
Females 334 111 333 174a 106 41 
Age       
18-–34 years 352 131 431 162 117 44 
35-–44 years 381 137 290 151 91 42 
45 years and 
over 
322 124 318 179 104 48 
Most 
frequently 
used drug 
      
Yes 479 155 561a 135a 132 48 
No 257 113 290 126 76 40 
Frequency of 
use last 30 
days 
      
1-–3 days 216 115 214 135 72 45 
3-–9 days 266 106 495a 165a 22 34 
10-–19 days 301 124 426a 277a 70 35 
20 days or 
more 
453 148 778a 182a 125 48 
City       
 Amphetamines Cocaine Heroin 
Quantity last 
day of use, 
pure (n = 277) 
Usual 
dose, pure 
(n = 277) 
Quantity last 
day of use, 
pure (n = 53) 
Usual 
dose, 
pure (n = 
45) 
Quantity last 
day of use, 
pure (n = 236) 
Usual 
dose, pure 
(n = 239) 
Arendal 510 154 400a 54a 89 30 
Tromsø 379 123 330 74 68 32 
Oslo 294 125 292 139 111 48 
aLess than ten respondents. 
5 Discussion 
Gender and age group were less important than frequency of use during the 
last 30 days and the main drug last used over 12 months for establishing differences 
in “consumption last day of use” and the “usual dose” of amphetamines, cocaine and 
heroin among marginalized drug users. Almost all users reported use any day of the 
week. There were some differences between the cities in the survey, pointing at local 
differences in the quantities consumed. 
Use of amphetamines and heroin was more common than use of cocaine and 
crack in this survey. This is in accordance with other studies of hard drug use in 
Norway (Amundsen and Bretteville-Jensen, 2010). The age and gender distribution is 
also close to samples from other studies. The low number of cocaine users (see Table 
2) reduced the value of the analysis for this substance, but the results are shown since 
there are few sources of such information. 
There are few surveys among marginalized drug users to which to compare 
these results. In an evaluation of a heroin injection room in Oslo, the average 
injection dose of heroin was 230 mg and the average number of injections per day 
was reported to be 3.2, yielding a daily consumption of 736 mg of heroin (Olsen and 
Skretting, 2007). In our study the figure for Oslo was 743 mg, a very close estimate. 
The average purity of heroin declined between 2005–2006 and 2010–2011, however. 
Studies have been carried out among cocaine users in the early 90s, but 
mainly among ‘non-problematic’ or ‘non-deviant’ users. In one such study from 
Amsterdam, the users reported an average dose of 444 mg in periods of their heaviest 
use (Cohen and Sas, 1994). This is close to the figure of 487 mg found in our survey. 
The purity was assumed to be higher, however. Based on the samples in 1991 bought 
from non-abstinent respondents in Amsterdam, the purity varied between 74 and 
96% and the mean was 87% In our country the mean was 33% in 2011. 
Self-reported behavior may be subject to biases and uncertainties. The 
reliability and validity of self-reported illegal drug use have been studied in different 
populations; among young people, in the general populations, among patients in drug 
treatment, mental health patients and in marginalized drug-using populations. This 
study was carried out in the last type of population, where there was no punishment 
for the reporting of drugs and no positive evaluation for not reporting taking them. In 
such situations, the reliability and validity of self-reports are respectable when 
compared to biomarkers (Darke, 1998; Napper et al., 2010; Nyamathi et al., 2001). 
Darke (1998) concluded that self-reports are sufficiently reliable and valid to provide 
descriptions of drug use, drug related problems and the natural history of drug use. 
Results are different among young people (mainly under-reporting), addicted 
persons waiting for treatment (reporting too high) and those reporting about drug 
use within or after treatment (under-reporting) (Magura and Kang, 1996). 
In this survey there were no measurements of the weight of the drug, nor of its 
purity. This is a common situation (Evrard et al., 2010). Self-reports of the quantities 
consumed will thus rely on information from the dealers at the street level. Purity was 
based on scarce information from analyses carried out by the central police 
laboratory of all seizures by the police and customs (see Table 1). This is by no means 
satisfactory. Content and purity can, however, be measured by gas phase 
chromatography and mass spectrometry on site using tiny quantities. With a survey 
design which includes measurements of both content and purity, much better 
information can be established (Evrard et al., 2010; Brunt, Niesink, 2011). It may be a 
challenge, however, to obtain the agreement of the user to test their drugs. It is also 
difficult to establish whether the samples tested are representative of consumption of 
the drugs among all drug users – — or a segment of them. 
The first comparison between waste water measures and surveys regarding the 
community use of cocaine found that the combined survey quantity/frequency (QF) 
estimate (117 (CI 70–165) kg/per year of pure cocaine) was not significantly different 
from the waste water estimate (76 (sensitivity interval 60–91) kg/per year of pure 
cocaine) (Reid et al., 2012). The knowledge of quantities in the QF approach was 
sparse, however; only data from Arendal was known, in addition to anecdotal 
knowledge and surveys from the beginning of the 90s. The quantity of cocaine found 
for use on the last day of use (reported 1014 g, 335 pure) in the three city survey was, 
however, somewhat higher than the quantities assumed for marginalized users by 
Reid et al. (2012). Thus the comparison of the combined survey method and the 
waste water method did not change when this new information was included. There 
may be other errors in the combined survey approach, however, such as errors in 
consumption among recreational users and errors in the frequency distributions for 
all groups. But the waste water method may also have weaknesses, one of them being 
the “back calculation” from the metabolite or substance measured in the waste water 
to the quantity actually consumed (Reid et al., 2011). 
Comparisons of consumption of amphetamines and heroin between the waste 
water and QF methods must take the quantity of doctor prescribed medications taken 
by the general population into account. Amphetamines, for example, are found in 
prescribed drugs to treat attention deficit hyperactivity disorder (ADHD). Regarding 
heroin comparisons, the main problem is that the drug quickly undergoes 
metabolism to other compounds which cannot be distinguished from agents in 
commonly prescribed medications (for example morphine). Also, in addition to the 
prescribed use of such drugs, there is an overflow to illegal consumption. Surveys 
among drug users should therefore include illegal (and legal) use of such drugs. 
The variation in purity is one of the key difficulties with regard to the 
generalization of the results found here to those of other cities/areas, and also for the 
comparison of consumption estimates by waste water analysis. Changes in purity do 
not necessarily lead to changes in doses or quantities, however. The users’' 
perception of the quality of a drug does not, for example, coincide with the purity or 
the type of cutting agent. Regarding cocaine, Evrard (2010) concluded that the 
composition was largely unknown to users and that the user’'s perceptions of cocaine 
quality were based partly on false beliefs and certain administrative methods. 
Therefore the quantity consumed was not necessarily increased or reduced according 
to their knowledge of purity. Otherwise the variation in consumption may vary with 
many factors: development of tolerance, prices and availability, economic 
possibilities, social norms and established practices, as well as factors related to the 
availability of harm reduction measures and treatment. 
6 Conclusions 
Measurements of the quantities consumed by individual drug users are 
essential for calculating the total drug consumption in a community by the quantity-–
frequency method, and are extremely important for the comparison with waste water 
derived consumption estimates. Self-reported quantities of drugs consumed were 
investigated in three cities in Norway and were found to be equal to or somewhat 
higher among marginalized users than previously assumed, when assumptions were 
based on limited literature and anecdotal information. Drug purity is however 
highlighted as one of the most critical difficulties in the investigation and estimation 
of individual drug consumption. Variation in purity and in individual drug 
consumption should be subject to further research, as this work will be extremely 
useful to the triangulation and/or comparison of datasets generated by 
complementary methods in drug epidemiology. 
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